Benchmark Holdings plc (BHCCF)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £m | 106 | 125 | 158 | 169 | 90 | - | 51 | 86 |
| Operating profit | £m | -35 | -40 | ||||||
| Net profit | £m | -33 | -13 | -32 | -23 | -39 | - | 46 | - |
| EPS reported | £ | -0.05 | 0.07 | ||||||
| Operating cashflow per share | £ | 0.00 | 0.00 | ||||||
| Capex per share | £ | 0.01 | 0.01 | ||||||
| FCF per share | £ | -0.00 | -0.00 | ||||||
| Free cash flow | £m | -2 | 2 | ||||||
| Net debt | £m | 45 | -129 | ||||||
| Book value equity | £m | 218 | 303 | ||||||
| Book value per share | £ | 0.30 | 0.41 | ||||||
| Number of shares | m | 739.58 | 741.29 | ||||||
| DPS (TTM paid) | £ | 0.00 | 0.00 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 4.36 | ||||||
| P/B LTM | x | 2.00 | 0.75 | ||||||
| P/S LTM | x | 4.83 | 1.50 | ||||||
| P/FCF LTM | x | -227.13 | -70.56 | ||||||
| EV/EBITDA LTM | x | 44.28 | 46.63 | ||||||
| EV/Sales LTM | x | 5.38 | 2.04 | ||||||
| Earnings Yield LTM | % | -9.04% | +22.94% | ||||||
| FCF Yield | % | -0.44% | +1.82% | ||||||
| Quality | |||||||||
| ROE | % | -18.08% | -15.96% | ||||||
| ROIC | % | -11.12% | -10.63% | ||||||
| Operating margin | % | -39.28% | -39.28% | ||||||
| Gross margin | % | +48.63% | +48.63% | ||||||
| FCF/Sales | % | -2.13% | -2.13% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -46.68% | -43.82% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -0.03 | 0.03 | ||||||
| Net Debt/EBITDA | x | 4.47 | 12.37 | ||||||
| EBIT/Net interest | x | -4.41 | -3.94 | ||||||
| Net debt/market cap | % | +15.67% | +50.44% | ||||||
| Net debt/Equity | x | 0.21 | -0.43 | ||||||
| Gross debt/equity | x | 0.33 | 0.27 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Benchmark Holdings plc is dedicated to empowering the food and agriculture sectors by furnishing specialized knowledge, services, and products. The company's operations are divided into three core divisions: Genetics, Advanced Nutrition, and Health. Within its Genetics arm, Benchmark provides cutting-edge breeding technologies and facilities for species such as sea bass/bream, salmon, shrimp, and tilapia, delivering genetically superior ova. The Advanced Nutrition division focuses on creating and supplying vital nutritional and health products specifically for the aquaculture industry. Meanwhile, the Health segment offers crucial medicinal solutions for the aquaculture market, including treatments like Ectosan Vet and CleanTreat for sea lice. Founded in 2000 and headquartered in Sheffield, United Kingdom, Benchmark Holdings plc maintains a broad international presence, conducting business in diverse regions including the UK, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, other European countries, and worldwide.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Benchmark Holdings plc is dedicated to empowering the food and agriculture sectors by furnishing specialized knowledge, services, and products. The company's operations are divided into three core divisions: Genetics, Advanced Nutrition, and Health. Within its Genetics arm, Benchmark provides cutting-edge breeding technologies and facilities for species such as sea bass/bream, salmon, shrimp, and tilapia, delivering genetically superior ova. The Advanced Nutrition division focuses on creating and supplying vital nutritional and health products specifically for the aquaculture industry. Meanwhile, the Health segment offers crucial medicinal solutions for the aquaculture market, including treatments like Ectosan Vet and CleanTreat for sea lice. Founded in 2000 and headquartered in Sheffield, United Kingdom, Benchmark Holdings plc maintains a broad international presence, conducting business in diverse regions including the UK, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, other European countries, and worldwide.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free